Dow Down 0.22% Nasdaq Up 0.14%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
43.82 Up 1.88(4.48%) Aug 22, 4:00PM EDT
Prev Close:41.94
Open:41.98
Bid:41.76 x 100
Ask:43.85 x 300
1y Target Est:81.11
Beta:2.08
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:41.66 - 43.87
52wk Range:35.33 - 93.33
Volume:519,353
Avg Vol (3m):867,233
Market Cap:1.49B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 4.48%1.49B
IMMUUp 3.30%287.26M
LRUSFUp 1.78%58.10M
THLDDown 1.23%238.65M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):104.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback